SCHEMBL411207

SCHEMBL411207

Cc1cc(N=Nc2ccccc2C)ccc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 1.00
▸ MAPK1 P28482 4/20 1.00
▸ CYP3A4 P08684 4/20 1.00
▸ TSHR P16473 3/20 1.00
▸ TP53 P04637 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ MEN1 O00255 6/20 0.69
▸ KMT2A Q03164 6/20 0.69
▸ NPC1 O15118 5/20 0.56
▸ MAPT P10636 5/20 0.56
▸ RAB9A P51151 4/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ USP2 O75604 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ L3MBTL1 Q9Y468 4/20 0.47
▸ PKM P14618 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ GLO1 Q04760 1/20 0.46
▸ GFER P55789 1/20 0.44
▸ AHR P35869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL411206 1.00 TDP1 (1.00) TDP1MAPK1CYP3A4TSHRTP53
SCHEMBL13338328 1.00 TDP1 (1.00) TDP1MAPK1CYP3A4TSHRTP53
SCHEMBL30777311 1.00 TDP1 (1.00) TDP1MAPK1CYP3A4TSHRTP53
SCHEMBL29405351 1.00 TDP1 (1.00) TDP1MAPK1CYP3A4TSHRTP53
Hydrochloric Acid SCHEMBL7536593 0.98 TDP1 (0.97) TDP1MAPK1CYP3A4TSHRTP53
Hydrochloric Acid SCHEMBL7536588 0.98 TDP1 (0.97) TDP1MAPK1CYP3A4TSHRTP53
Hydrochloric Acid SCHEMBL30387748 0.98 TDP1 (0.97) TDP1MAPK1CYP3A4TSHRTP53
SCHEMBL28129251 0.86 MAPK1 (0.76) TDP1MAPK1CYP3A4TSHRTP53
Betanaphthol SCHEMBL11484254 0.85 MAPK1 (0.72) TDP1MAPK1CYP3A4TSHRTP53
SCHEMBL11647594 0.84 TDP1 (0.71) TDP1MAPK1CYP3A4TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12522723-B2 Polypropylene thermoplastic resin composition and molded article manufactured using the same HYUNDAI MOTOR COMPANY (KR) 2026-01-13 — — US claimed
US-20250329715-A1 COMPOSITIONS AND METHODS FOR ENERGY STORAGE DEVICES INCLUDING SALTS AND/OR FOAMS TESLA INC (US) 2025-10-23 — — US claimed
US-20250251347-A1 PORTABLE LIQUID ANALYZER VERITEQUE USA INC (US) 2025-08-07 — — US claimed
EP-4594437-A1 CATIONICALLY CURABLE ADHESIVE WITH HOLDING-STRENGTH INDICATION TESA SE (DE) 2025-08-06 — — EP claimed
US-12300805-B2 Compositions and methods for energy storage devices including salts and/or foams TESLA, INC. (US) 2025-05-13 — — US claimed
CN-119968448-A Cationically curable adhesives with retained strength indication 德莎欧洲股份公司 2025-05-09 — — CN claimed
US-12195630-B2 Pigment ink dispersions, tattoo inks containing the pigment ink dispersions, and method of making the same BARTH MARIO (US) 2025-01-14 — — US claimed
EP-4479481-A1 PIGMENT INK DISPERSIONS, TATTOO INKS CONTAINING THE PIGMENT INK DISPERSIONS, AND METHOD OF MAKING THE SAME Intenze Products, Inc. (US) 2024-12-25 — — EP claimed
CN-119032141-A Pigment ink dispersion, tattoo ink comprising the pigment ink dispersion and method for the production thereof 银单丝产品公司 2024-11-26 — — CN claimed
US-11980628-B2 Prostate cancer treatment via synergistic inhibition of aryl hydrocarbon receptor (AhR) and SRC CLARK ATLANTA UNIVERSITY, INC. (US) 2024-05-14 — — US claimed
EP-1855643-B1 DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION OREAL (FR) 2011-08-03 — — EP claimed
US-7611545-B2 Cosmetic article and process for dry dyeing keratin materials L'OREAL S.A. (FR) 2009-11-03 — — US claimed
US-20080244837-A1 Cosmetic article and process for dry dyeing keratin materials L'OREAL S.A. (FR) 2008-10-09 — — US claimed
EP-1964539-A1 Cosmetic article for dyeing dry hair, its use, method of implementing said article L'Oréal (FR) 2008-09-03 — — EP claimed
US-20080148496-A1 Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation L'OREAL S.A. (FR) 2008-06-26 — — US claimed
US-4688713-A INSERTS, FLUX, HEAT SENSITIVE DYE RAYCHEM CORPORATION (US) 1987-08-25 — — US claimed
EP-0076681-B1 SOLDERING DEVICE AND METHOD RAYCHEM CORPORATION (a California corporation) (US) 1986-03-05 — — EP claimed
EP-0160752-A1 Soldering device and method RAYCHEM CORPORATION (a Delaware corporation) (US) 1985-11-13 — — EP claimed
US-4505421-A Soldering methods and devices RAYCHEM CORPORATION (US) 1985-03-19 — — US claimed
EP-0089506-A2 Light-sensitive mixture based on polycondensation products of diazonium salts, and light-sensitive recording material made therefrom AMERICAN HOECHST CORPORATION (US) 1983-09-28 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12195630-B2 Pigment ink dispersions, tattoo inks containing the pigment ink dispersions, and method of making the same TYR, TH, COMT TDP1 545/4885MAPK1 1408/4885CYP3A4 283/4885
US-20080244837-A1 Cosmetic article and process for dry dyeing keratin materials KRT18, CUTA, DSG1 TDP1 3293/4885MAPK1 1820/4885CYP3A4 2074/4885
US-20080148496-A1 Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation KRT18, IK, DSG1 TDP1 3318/4885MAPK1 2433/4885CYP3A4 500/4885
US-11980628-B2 Prostate cancer treatment via synergistic inhibition of aryl hydrocarbon receptor (AhR) and SRC AHR, AR, ARNT TDP1 2748/4885MAPK1 561/4885CYP3A4 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback